Absorable Sutures
First Absorbable Suture FDA cleared
Non-Surgical, IMMEDIATE AND LASTING LIFT
Silhouette InstaLift® is the only non-surgical rejuvenating procedure that uses advanced Micro-Suspension Technology™ to offer immediate and lasting results.*
MINIMAL DOWNTIME, LONG LASTING RESULTS
The procedure only takes under an hour and is done right in your doctor’s office. InstaLift also has minimal downtime with most signs of treatment (ex: bruising, swelling, and tenderness at the treatment site) dissipating within 24–48 hours. Patients can get right back to their activities and enjoy an instant lift in the cheeks, while adding volume over time for long lasting results.
MICRO SUSPENSION TECHNOLOGY™
Silhouette InstaLift® is a treatment unlike any other. Our Micro Suspension Technology™ is comprised of micro cones that are placed in the deepest layer of mid-facial skin. It delivers an immediate lift and gradually restores lost facial volume of the mid face by activating your own natural collagen production for a more youthful appearance that continues to improve over time. The sutures and cones are made from poly lactic-co-glycolic acid (PLGA), a well-known biomedical copolymer that is biocompatible and biodegradable 1,2,†
TREATMENT RESULTS
BEFORE AND AFTERS
ba 1 1
MODEL IS A REAL PATIENT TREATED WITH SILHOUETTE INSTALIFT BY YAEL HALAAS, MD. INDIVIDUAL TECHNIQUE AND RESULTS MAY VARY
WHITE PAPERS
Expert Consensus on Achieving Optimal Outcomes With Absorbable Suspension Suture Technology for Tissue Repositioning and Facial Recontouring
Silhouette InstaLift® in Minimally Invasive Tissue Repositioning for Facial Rejuvenation
• 8 cones (4 per side)
• 12 cones (6 per side)
• 16 cones (8 per side)
*A study of 100 patients treated with Silhouette InstaLift. Results were based on patient satisfaction surveys sent at 1 week post-treatment (n=28) and at 3 months posttreatment (n=47). Improvement in midfacial deficits was evaluated by clinical reviewers at 3 and 6 months post-treatment using a volume deficit scale (0=none, 1=minimal, 2=mild, 3=moderate, 4=significant, and 5=severe) (n=91). The majority of patients started with an average deficit of 3.Model is a real patient treated with Silhouette InstaLift by Tam Nguyen, MD. Individual technique and results may vary. †18% PGA/82% PLLA.
References: 1. Silhouette InstaLift® Instructions for Use. Sinclair Pharmaceuticals; 2019., 2. Ulery BD, Nair LS, Laurencin CT. Biomedical applications of biodegradable polymers. J Polym Sci B Polym Phys. 2011;49(12):832-864. 4. Nestor MS, Ablon G, Andriessen A, et al. Expert consensus on absorbable advanced suspension technology for facial tissue repositioning and volume enhancement. J Drugs Dermatol. 2017;16(7):661-666.
